Adial Pharmaceuticals, Inc.
ADIL
$0.68
$0.00520.77%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 2.55% | -7.44% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -12.25% | -3.31% | |||
| Operating Income | 12.25% | 3.31% | |||
| Income Before Tax | 5.52% | 10.84% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 5.52% | 10.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 5.52% | 10.84% | |||
| EBIT | 12.25% | 3.31% | |||
| EBITDA | 12.24% | 3.31% | |||
| EPS Basic | 14.06% | 36.09% | |||
| Normalized Basic EPS | -193.82% | 37.00% | |||
| EPS Diluted | 14.06% | 36.09% | |||
| Normalized Diluted EPS | -193.82% | 37.00% | |||
| Average Basic Shares Outstanding | 9.94% | 39.52% | |||
| Average Diluted Shares Outstanding | 9.94% | 39.52% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
